Color vision impairment in Parkinson's disease.

作者: Anna Piro , Antonio Tagarelli , Giuseppe Nicoletti , Robert Fletcher , Aldo Quattrone

DOI: 10.3233/JPD-140359

关键词: Diabetic retinopathyMaculopathyRetinaOptic neuritisOphthalmologyMedicinePopulationAdaptation (eye)Color visionRetinal

摘要: Acquired disturbances of color vision are a highly varied group defects with frequent departures from established patterns. They can progress normal trichromatism to anomalous on dichromatic stage and monochromatism where most is lost, or they may be relatively stable [1]. A significant “modern effort” present such conditions was published for first time in 1972 [2], attention drawn account given 15 years later by Jaeger Krastel emphasizing pharmaco-therapeutical effects [3]. Normally, dopaminergic neurons act the outer inner retina at multiple levels, producing alterations flow visual information complex fashion. Dopamine chemical messenger light adaptation, promoting through cone circuits while diminishing that rod [4]. Color relies photoreceptor population therefore largely confined central retina. Because there segregation color-specific retinal into blue-yellow red-green pathways, it possible use discrimination tasks assess ganglion cell subpopulations It has been reported impaired Parkinson’s disease (PD) [5] some works have suggested these affect predominantly short-wave pathway [6]. Birch acquired type three (tritan) defect level as an early diagnostic sign ∗Correspondence to: Anna Piro, Neuroimaging Research Unit, IBFM-CNR, Germaneto, Catanzaro, Italy. Tel.: +393402529194; Fax: +39 0 9613695919; E-mail: anna.piro@cnr.it. [7]. We examined 49 PD Calabrian all male patients (age range, 50–85 years, mean age, 67 years) avoid genetic appearance “lionization” which heterozygous females deficiency who mimic [8]. All underwent L-DOPA doses subdivided two different groups: 125–300 mg/day, low daily dose; 400–1000 high dose. 25 age sex matched controls showing vision, comparison (chi square = 25.3, df 1, p< 0.0005) were enrolled 25/49 bleu/yellow axis. Controls did not show any signs, other ophthalmological disease. After informed consent, patients, had examination ophthalmologist order rule diabetic retinopathy, cataract, optic neuritis, senile maculopathy, ocular fundus’ anomalies could influence analysis. made more than 5 mistakes during their reading 17 Ishihara plates diagnosed being color-blind, this diagnosis confirmed next four (numbers 18–21) plates. The last 22–25) utilized define color-blindness (the red green colorbindness) grade color-blindness: protanopy, absence protanomaly, small deuteranopy, deuteranomaly, [9]. colorblind excluded So,

参考文章(10)
Dean Farnsworth, The Farnsworth-Munsell 100-Hue and Dichotomous Tests for Color Vision* Journal of the Optical Society of America. ,vol. 33, pp. 568- 578 ,(1943) , 10.1364/JOSA.33.000568
Jennifer Birch, Renate U Kolle, M Kunkel, Walter Paulus, Pushpa Upadhyay, Acquired colour deficiency in patients with Parkinson's disease. Vision Research. ,vol. 38, pp. 3421- 3426 ,(1998) , 10.1016/S0042-6989(97)00398-2
Th. Büttner, T. Patzold, W. Kuhn, Th. Müller, H. Przuntek, Spontaneous remission of papilledema and sixth nerve palsy in acute lymphoblastic leukemia. Journal of Neuro-ophthalmology. ,vol. 14, pp. 91- 94 ,(1994) , 10.3109/01658109409024031
Miguel Castelo-Branco, Pedro Faria, Vasco Forjaz, Lajos R. Kozak, Helena Azevedo, Simultaneous comparison of relative damage to chromatic pathways in ocular hypertension and glaucoma: correlation with clinical measures. Investigative Ophthalmology & Visual Science. ,vol. 45, pp. 499- 505 ,(2004) , 10.1167/IOVS.03-0815
MARY F. LYON, Gene Action in the X -chromosome of the Mouse ( Mus musculus L.) Nature. ,vol. 190, pp. 372- 373 ,(1961) , 10.1038/190372A0
MF Silva, P Faria, FS Regateiro, V Forjaz, C Januário, A Freire, M Castelo-Branco, None, Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinson's disease. Brain. ,vol. 128, pp. 2260- 2271 ,(2005) , 10.1093/BRAIN/AWH581
Vivianne C. Smith, Joel Pokorny, Spectral sensitivity of color-blind observers and the cone photopigments Vision Research. ,vol. 12, pp. 2059- 2071 ,(1972) , 10.1016/0042-6989(72)90058-2
N. K. Archibald, M. P. Clarke, U. P. Mosimann, D. J. Burn, The retina in Parkinson's disease Brain. ,vol. 132, pp. 1128- 1145 ,(2009) , 10.1093/BRAIN/AWP068
Bernhard A. Haug, Renate U. Kolle, Claudia Trenkwalder, Wolfgang H. Oertel, Walter Paulus, Predominant affection of the blue cone pathway in Parkinson's disease. Brain. ,vol. 118, pp. 771- 778 ,(1995) , 10.1093/BRAIN/118.3.771